Oxbridge Re Stock Forecast, Price & News

Oxbridge Re (NASDAQ:OXBR) Frequently Asked Questions

How has Oxbridge Re's stock price been impacted by Coronavirus?

Oxbridge Re's stock was trading at $1.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OXBR shares have increased by 338.0% and is now trading at $4.73.
View which stocks have been most impacted by COVID-19.

Are investors shorting Oxbridge Re?

Oxbridge Re saw a increase in short interest in November. As of November 15th, there was short interest totaling 54,600 shares, an increase of 139.5% from the October 31st total of 22,800 shares. Based on an average daily volume of 300,500 shares, the days-to-cover ratio is presently 0.2 days. Approximately 1.2% of the shares of the company are short sold.
View Oxbridge Re's Short Interest.

When is Oxbridge Re's next earnings date?

Oxbridge Re is scheduled to release its next quarterly earnings announcement on Monday, April 4th 2022.
View our earnings forecast for Oxbridge Re.

Who are Oxbridge Re's key executives?

Oxbridge Re's management team includes the following people:

• Sanjay Madhu, Chairman, President & Chief Executive Officer
• Wrendon Timothy, Secretary, Chief Financial & Accounting Officer

Who are some of Oxbridge Re's key competitors?

Some companies that are related to Oxbridge Re include First Acceptance (FACO), ICC (ICCH), Kingstone Companies (KINS), Positive Physicians (PPHI), FedNat (FNHC), Conifer (CNFR), FG Financial Group (FGF), The Seibels Bruce Group (SBBG), Unico American (UNAM), Till Capital (TILCF), Atlas Financial (AFHIF), Blue Capital Reinsurance (BCRHF) and Majestic Capital (MAJCQ).
View all of OXBR's competitors.

What other stocks do shareholders of Oxbridge Re own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxbridge Re investors own include Bionano Genomics (BNGO), OrganiGram (OGI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Cannabics Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and Evolve Transition Infrastructure (SNMP).

What is Oxbridge Re's stock symbol?

Oxbridge Re trades on the NASDAQ under the ticker symbol "OXBR."

Who are Oxbridge Re's major shareholders?

Oxbridge Re's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (1.61%), Dimensional Fund Advisors LP (0.74%), Schonfeld Strategic Advisors LLC (0.29%) and Morgan Stanley (0.26%).
View institutional ownership trends for Oxbridge Re.

Which major investors are selling Oxbridge Re stock?

OXBR stock was sold by a variety of institutional investors in the last quarter, including Schonfeld Strategic Advisors LLC, and Dimensional Fund Advisors LP.
View insider buying and selling activity for Oxbridge Re or view top insider-selling stocks.

Which major investors are buying Oxbridge Re stock?

OXBR stock was purchased by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, and Morgan Stanley.
View insider buying and selling activity for Oxbridge Re or or view top insider-buying stocks.

How do I buy shares of Oxbridge Re?

Shares of OXBR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Oxbridge Re's stock price today?

One share of OXBR stock can currently be purchased for approximately $4.73.

How much money does Oxbridge Re make?

Oxbridge Re has a market capitalization of $27.10 million and generates $1.21 million in revenue each year. The insurance provider earns $-50 thousand in net income (profit) each year or $0.10 on an earnings per share basis.

How many employees does Oxbridge Re have?

Oxbridge Re employs 3 workers across the globe.

What is Oxbridge Re's official website?

The official website for Oxbridge Re is www.oxbridgere.com.

Where are Oxbridge Re's headquarters?

Oxbridge Re is headquartered at SUITE 201 42 EDWARD STREET PO BOX 469, GEORGE TOWN E9, KY1-9006.

How can I contact Oxbridge Re?

Oxbridge Re's mailing address is SUITE 201 42 EDWARD STREET PO BOX 469, GEORGE TOWN E9, KY1-9006. The insurance provider can be reached via phone at (345) 749-7570.